Anti-ITCH/AIP4 (phospho Y420) antibody (ab111488)


  • Product nameAnti-ITCH/AIP4 (phospho Y420) antibody
    See all ITCH/AIP4 primary antibodies
  • Description
    Rabbit polyclonal to ITCH/AIP4 (phospho Y420)
  • Specificityab111488 detects endogenous levels of ITCH/AIP4 only when phosphorylated at tyrosine 420 (Human: Tyr420; Mouse: Tyr381).
  • Tested applicationsSuitable for: IHC-Pmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse
  • Immunogen

    Synthetic phosphopeptide derived from Human ITCH/AIP4 around the phosphorylation site of tyrosine 420 (F-I-YP-G-N).

  • Positive control
    • Human brain tissue


  • FormLiquid
  • Storage instructionsShipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
  • Storage bufferpH: 7.40
    Preservative: 0.02% Sodium azide
    Constituents: 50% Glycerol, 49% PBS, 0.88% Sodium chloride
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • Purification notesab111488 was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas


Our Abpromise guarantee covers the use of ab111488 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P 1/50 - 1/100. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.


  • FunctionActs as an E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. It catalyzes 'Lys-29'-, 'Lys-48'- and 'Lys-63'-linked ubiquitin conjugation. It is involved in the control of inflammatory signaling pathways. Is an essential component of a ubiquitin-editing protein complex, comprising also TNFAIP3, TAX1BP1 and RNF11, that ensures the transient nature of inflammatory signaling pathways. Promotes the association of the complex after TNF stimulation. Once the complex is formed, TNFAIP3 deubiquitinates 'Lys-63' polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains. This leads to RIPK1 proteosomal degradation and consequently termination of the TNF- or LPS-mediated activation of NFKB1. Ubiquitinates RIPK2 by 'Lys-63'-linked conjugation and influences NOD2-dependent signal transduction pathways. Regulates the transcriptional activity of several transcription factors, and probably plays an important role in the regulation of immune response. Ubiquitinates NFE2 by 'Lys-63' linkages and is implicated in the control of the development of hematopoietic lineages. Critical regulator of T helper (TH2) cytokine development through its ability to induce JUNB ubiquitination and degradation (By similarity). Ubiquitinates SNX9. Ubiquitinates CXCR4 and HGS/HRS and regulates sorting of CXCR4 to the degradative pathway. It is involved in the negative regulation of MAVS-dependent cellular antiviral responses. Ubiquitinates MAVS through 'Lys-48'-linked conjugation resulting in MAVS proteosomal degradation. Involved in the regulation of apoptosis and reactive oxygen species levels through the ubiquitination and proteosomal degradation of TXNIP. Mediates the antiapoptotic activity of epidermal growth factor through the ubiquitination and proteosomal degradation of p15 BID. Targets DTX1 for lysosomal degradation and controls NOTCH1 degradation, in the absence of ligand, through 'Lys-29'-linked polyubiquitination.
  • Tissue specificityWidely expressed.
  • PathwayProtein modification; protein ubiquitination.
  • Involvement in diseaseDefects in ITCH are the cause of syndromic multisystem autoimmune disease (SMAD) [MIM:613385]. SMAD is characterized by organomegaly, failure to thrive, developmental delay, dysmorphic features and autoimmune inflammatory cell infiltration of the lungs, liver and gut.
  • Sequence similaritiesContains 1 C2 domain.
    Contains 1 HECT (E6AP-type E3 ubiquitin-protein ligase) domain.
    Contains 4 WW domains.
  • Post-translational
    On T-cell activation, phosphorylation by the JNK cascade on serine and threonine residues surrounding the PRR domain accelerates the ubiquitination and degradation of JUN and JUNB. The increased ITCH catalytic activity due to phosphorylation by JNK1 may occur due to a conformational change disrupting the interaction between the PRR/WW motifs domain and the HECT domain and, thus exposing the HECT domain (By similarity). Phosphorylation by FYN reduces interaction with JUNB and negatively controls JUN ubiquitination and degradation.
    Ubiquitinated; autopolyubiquitination with 'Lys-63' linkages which does not lead to protein degradation.
  • Cellular localizationCell membrane. Cytoplasm. Nucleus. Associates with endocytic vesicles. May be recruited to exosomes by NDFIP1.
  • Information by UniProt
  • Database links
  • Alternative names
    • ADMFD antibody
    • AIF4 antibody
    • AIP4 antibody
    • Atrophin 1 interacting protein 4 antibody
    • Atrophin-1-interacting protein 4 antibody
    • dJ468O1.1 antibody
    • dJ468O1.1 (atrophin 1 interacting protein 4 (AIP4)) antibody
    • dJ468O1.1 atrophin 1 interacting protein 4 AIP4 antibody
    • E3 ubiquitin protein ligase Itchy homolog antibody
    • E3 ubiquitin-protein ligase Itchy homolog antibody
    • EC 6.3.2 antibody
    • Itch antibody
    • ITCH_HUMAN antibody
    • Itchy E3 ubiquitin protein ligase antibody
    • Itchy E3 ubiquitin protein ligase homolog antibody
    • Itchy E3 ubiquitin protein ligase homolog mouse antibody
    • Itchy E3 ubiquitin protein ligase, mouse, homolog of antibody
    • Itchy homolog E3 ubiquitin protein ligase antibody
    • Itchy mouse homolog E3 ubiquitin protein ligase antibody
    • NAPP1 antibody
    • NFE2 associated polypeptide 1 antibody
    • NFE2-associated polypeptide 1 antibody
    • Ubiquitin protein ligase ITCH antibody
    see all

Anti-ITCH/AIP4 (phospho Y420) antibody images

  • ab111488, at 1/50 dilution, staining ITCH/AIP4 in paraffin-embedded Human brain tissue by Immunohistochemistry, in the presence (right panel) or absence (left panel) of immunising peptide.

References for Anti-ITCH/AIP4 (phospho Y420) antibody (ab111488)

ab111488 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab111488.
Please use the links above to contact us or submit feedback about this product.